Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The objective of this investigation is to evaluate the safety and efficacy of long term use
with Lyrica in medical practice. Also, occurrence of unknown and known adverse drug reactions
(ADRs) in subjects treated with Lyrica will be monitored during the survey period, and
whether an additional treatment outcome investigation and/or a post-marketing clinical study
is required in the future will be determined.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.